Novo, e-therapeutics extend Type 2 diabetes research pact by Conor Hale Thursday, August 1, 2019 Novo Nordisk and e-therapeutics have extended their drug discovery collaboration in Type 2 diabetes to incorporate a new approach to genomic data.
